249 related articles for article (PubMed ID: 25596698)
41. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
42. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
Park S; James CD
Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319
[TBL] [Abstract][Full Text] [Related]
43. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
[TBL] [Abstract][Full Text] [Related]
44. Pgp efflux pump decreases the cytostatic effect of CENP-E inhibitor GSK923295.
Tcherniuk SO; Oleinikov AV
Cancer Lett; 2015 May; 361(1):97-103. PubMed ID: 25725449
[TBL] [Abstract][Full Text] [Related]
45. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
Lee SY; Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Jung MH; Kim SH; Lee EO; Ahn KS; Ahn KS; Kim SH
Environ Toxicol; 2011 Aug; 26(4):424-31. PubMed ID: 20196146
[TBL] [Abstract][Full Text] [Related]
46. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
47. Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticles.
Zalba S; Seynhaeve ALB; Brouwers JF; Süss R; Verheij M; Ten Hagen TLM
Nanoscale; 2020 Aug; 12(32):16967-16979. PubMed ID: 32780078
[TBL] [Abstract][Full Text] [Related]
48. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
49. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.
Hung TH; Li YH; Tseng CP; Lan YW; Hsu SC; Chen YH; Huang TT; Lai HC; Chen CM; Choo KB; Chong KY
Cancer Gene Ther; 2015 May; 22(5):262-70. PubMed ID: 25908454
[TBL] [Abstract][Full Text] [Related]
51. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
52. Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin.
Olsen CE; Berg K; Selbo PK; Weyergang A
Free Radic Biol Med; 2013 Dec; 65():1300-1309. PubMed ID: 24076428
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
54. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
55. Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells.
Li J; Liu H; Yu J; Yu H
Mol Med Rep; 2015 Jul; 12(1):192-8. PubMed ID: 25684678
[TBL] [Abstract][Full Text] [Related]
56. Cellular prion protein contributes to LS 174T colon cancer cell carcinogenesis by increasing invasiveness and resistance against doxorubicin-induced apoptosis.
Chieng CK; Say YH
Tumour Biol; 2015 Sep; 36(10):8107-20. PubMed ID: 25983001
[TBL] [Abstract][Full Text] [Related]
57. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice.
Peluso JJ; Gawkowska A; Liu X; Shioda T; Pru JK
Endocrinology; 2009 Nov; 150(11):4846-54. PubMed ID: 19797399
[TBL] [Abstract][Full Text] [Related]
58. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
59. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
Rohe HJ; Ahmed IS; Twist KE; Craven RJ
Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
[TBL] [Abstract][Full Text] [Related]
60. Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein.
Villar VH; Vögler O; Barceló F; Gómez-Florit M; Martínez-Serra J; Obrador-Hevia A; Martín-Broto J; Ruiz-Gutiérrez V; Alemany R
J Nutr Biochem; 2014 Apr; 25(4):429-38. PubMed ID: 24491315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]